Matches in Nanopublications for { ?s ?p "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP108450.RAIwqQhDC8IwBn54Ij6KkegiTCT_AGbkfW5weo2yY7Z20130_assertion description "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108450.RAIwqQhDC8IwBn54Ij6KkegiTCT_AGbkfW5weo2yY7Z20130_provenance.
- NP171664.RAQcvC1jJjVnwiTGiWwOGvO40TN7ebqCrWR82fhNOZY7g130_assertion description "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171664.RAQcvC1jJjVnwiTGiWwOGvO40TN7ebqCrWR82fhNOZY7g130_provenance.
- assertion description "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP171653.RAnD9cOW6FIcw3-Wey9FKa6lSp4oJwbG5nSWmrc11aKKo130_assertion description "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171653.RAnD9cOW6FIcw3-Wey9FKa6lSp4oJwbG5nSWmrc11aKKo130_provenance.
- NP244840.RAKZMx9ypBX2M5r18JJZPSCSTOkVagBehxuIE2jemcE4o130_assertion description "[Life time risks for CHEK2 1100delC carrier and noncarrier daughters of bilateral breast cancer cases of 37% and 18%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244840.RAKZMx9ypBX2M5r18JJZPSCSTOkVagBehxuIE2jemcE4o130_provenance.